Intech Investment Management LLC lifted its position in Maximus, Inc. (NYSE:MMS - Free Report) by 127.4% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 173,478 shares of the health services provider's stock after buying an additional 97,180 shares during the period. Intech Investment Management LLC owned approximately 0.31% of Maximus worth $11,829,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds also recently bought and sold shares of the company. LRI Investments LLC boosted its position in shares of Maximus by 11.9% during the first quarter. LRI Investments LLC now owns 1,833 shares of the health services provider's stock valued at $125,000 after buying an additional 195 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Maximus by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider's stock valued at $2,351,000 after purchasing an additional 221 shares during the last quarter. Vestcor Inc lifted its position in shares of Maximus by 2.3% during the 1st quarter. Vestcor Inc now owns 9,877 shares of the health services provider's stock worth $674,000 after purchasing an additional 223 shares during the last quarter. Cetera Investment Advisers boosted its holdings in Maximus by 5.8% during the first quarter. Cetera Investment Advisers now owns 4,519 shares of the health services provider's stock worth $308,000 after buying an additional 247 shares in the last quarter. Finally, UMB Bank n.a. increased its position in Maximus by 70.2% during the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock worth $41,000 after purchasing an additional 250 shares during the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.
Maximus Price Performance
Shares of NYSE MMS traded down $0.41 during mid-day trading on Tuesday, reaching $87.56. The company had a trading volume of 155,521 shares, compared to its average volume of 569,141. Maximus, Inc. has a one year low of $63.77 and a one year high of $93.94. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27. The business's 50-day simple moving average is $80.23 and its 200 day simple moving average is $73.36. The firm has a market cap of $4.93 billion, a price-to-earnings ratio of 16.15 and a beta of 0.61.
Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.77. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The firm's quarterly revenue was up 2.5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.74 earnings per share. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. On average, research analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.
Maximus Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Sunday, August 31st. Shareholders of record on Friday, August 15th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. Maximus's payout ratio is presently 22.10%.
Analyst Ratings Changes
Separately, Zacks Research raised shares of Maximus from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 26th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the stock. According to MarketBeat, Maximus currently has a consensus rating of "Strong Buy" and an average price target of $90.00.
Get Our Latest Stock Analysis on MMS
About Maximus
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Stories

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.